72 related articles for article (PubMed ID: 9117311)
21. Risk of congestive heart failure with nonsteroidal antiinflammatory drugs and selective Cyclooxygenase 2 inhibitors: a class effect?
Hudson M; Rahme E; Richard H; Pilote L
Arthritis Rheum; 2007 Apr; 57(3):516-23. PubMed ID: 17394181
[TBL] [Abstract][Full Text] [Related]
22. The relationship of nonsteroidal anti-inflammatory drug use to the risk of breast cancer.
Coogan PF; Rao SR; Rosenberg L; Palmer JR; Strom BL; Zauber AG; Stolley PD; Shapiro S
Prev Med; 1999 Aug; 29(2):72-6. PubMed ID: 10446030
[TBL] [Abstract][Full Text] [Related]
23. Hospitalization for gastrointestinal adverse events attributable to the use of low-dose aspirin among patients 50 years or older also using non-steroidal anti-inflammatory drugs: a retrospective cohort study.
Rahme E; Nedjar H; Bizzi A; Morin S
Aliment Pharmacol Ther; 2007 Nov; 26(10):1387-98. PubMed ID: 17892525
[TBL] [Abstract][Full Text] [Related]
24. Non-steroidal anti-inflammatory drugs, lower oesophageal sphincter-relaxing drugs and oesophageal cancer. A case-control study.
Ranka S; Gee JM; Johnson IT; Skinner J; Hart AR; Rhodes M
Digestion; 2006; 74(2):109-15. PubMed ID: 17167266
[TBL] [Abstract][Full Text] [Related]
25. Determinants and sequelae associated with utilization of acetaminophen versus traditional nonsteroidal antiinflammatory drugs in an elderly population.
Rahme E; Pettitt D; LeLorier J
Arthritis Rheum; 2002 Nov; 46(11):3046-54. PubMed ID: 12428249
[TBL] [Abstract][Full Text] [Related]
26. Factors associated with celecoxib and rofecoxib utilization.
Rawson NS; Nourjah P; Grosser SC; Graham DJ
Ann Pharmacother; 2005 Apr; 39(4):597-602. PubMed ID: 15755796
[TBL] [Abstract][Full Text] [Related]
27. Selective and non-selective non-steroidal anti-inflammatory drugs and the risk of acute kidney injury.
Lafrance JP; Miller DR
Pharmacoepidemiol Drug Saf; 2009 Oct; 18(10):923-31. PubMed ID: 19585463
[TBL] [Abstract][Full Text] [Related]
28. COX-2 inhibitors: complex association with lower risk of hospitalization for gastrointestinal events compared to traditional NSAIDs plus proton pump inhibitors.
van der Linden MW; Gaugris S; Kuipers EJ; van Herk-Sukel MP; van den Bemt BJ; Sen SS; Herings RM
Pharmacoepidemiol Drug Saf; 2009 Oct; 18(10):880-90. PubMed ID: 19593747
[TBL] [Abstract][Full Text] [Related]
29. Utilization of non-steroidal anti-inflammatory drugs in Quebec: adherence to the Canadian consensus on prescription guidelines.
Moride Y; Ducruet T; Boivin JF; Lavoie F; Rochon S
Can J Clin Pharmacol; 2005; 12(2):e201-11. PubMed ID: 15998959
[TBL] [Abstract][Full Text] [Related]
30. Prescription channeling of COX-2 inhibitors and traditional nonselective nonsteroidal anti-inflammatory drugs: a population-based case-control study.
Moride Y; Ducruet T; Boivin JF; Moore N; Perreault S; Zhao S
Arthritis Res Ther; 2005; 7(2):R333-42. PubMed ID: 15743481
[TBL] [Abstract][Full Text] [Related]
31. Genetic susceptibility to nonsteroidal anti-inflammatory drug-related gastroduodenal bleeding: role of cytochrome P450 2C9 polymorphisms.
Pilotto A; Seripa D; Franceschi M; Scarcelli C; Colaizzo D; Grandone E; Niro V; Andriulli A; Leandro G; Di Mario F; Dallapiccola B
Gastroenterology; 2007 Aug; 133(2):465-71. PubMed ID: 17681167
[TBL] [Abstract][Full Text] [Related]
32. Severe necrotizing soft-tissue infections and nonsteroidal anti-inflammatory drugs.
Souyri C; Olivier P; Grolleau S; Lapeyre-Mestre M;
Clin Exp Dermatol; 2008 May; 33(3):249-55. PubMed ID: 18261144
[TBL] [Abstract][Full Text] [Related]
33. Potential limitations of electronic database studies of prescription non-aspirin non-steroidal anti-inflammatory drugs (NANSAIDs) and risk of myocardial infarction (MI).
Ilkhanoff L; Lewis JD; Hennessy S; Berlin JA; Kimmel SE
Pharmacoepidemiol Drug Saf; 2005 Aug; 14(8):513-22. PubMed ID: 15959879
[TBL] [Abstract][Full Text] [Related]
34. Non-steroidal anti-inflammatory drugs and perforated diverticular disease: a case-control study.
Goh H; Bourne R
Ann R Coll Surg Engl; 2002 Mar; 84(2):93-6. PubMed ID: 11995772
[TBL] [Abstract][Full Text] [Related]
35. Nonsteroidal anti-inflammatory drugs and increased risk of acute urinary retention.
Verhamme KM; Dieleman JP; Van Wijk MA; van der Lei J; Bosch JL; Stricker BH; Sturkenboom MC
Arch Intern Med; 2005 Jul; 165(13):1547-51. PubMed ID: 16009872
[TBL] [Abstract][Full Text] [Related]
36. Risk of anastomotic leakage with non-steroidal anti-inflammatory drugs in colorectal surgery.
Gorissen KJ; Benning D; Berghmans T; Snoeijs MG; Sosef MN; Hulsewe KW; Luyer MD
Br J Surg; 2012 May; 99(5):721-7. PubMed ID: 22318712
[TBL] [Abstract][Full Text] [Related]
37. Risk of hospitalization for myocardial infarction among users of rofecoxib, celecoxib, and other NSAIDs: a population-based case-control study.
Johnsen SP; Larsson H; Tarone RE; McLaughlin JK; Nørgård B; Friis S; Sørensen HT
Arch Intern Med; 2005 May; 165(9):978-84. PubMed ID: 15883235
[TBL] [Abstract][Full Text] [Related]
38. Risk of congenital anomalies in pregnant users of non-steroidal anti-inflammatory drugs: A nested case-control study.
Ofori B; Oraichi D; Blais L; Rey E; Bérard A
Birth Defects Res B Dev Reprod Toxicol; 2006 Aug; 77(4):268-79. PubMed ID: 16929547
[TBL] [Abstract][Full Text] [Related]
39. Analysis of the nonsteroidal anti-inflammatory drug literature for potential developmental toxicity in rats and rabbits.
Cook JC; Jacobson CF; Gao F; Tassinari MS; Hurtt ME; DeSesso JM
Birth Defects Res B Dev Reprod Toxicol; 2003 Feb; 68(1):5-26. PubMed ID: 12852480
[TBL] [Abstract][Full Text] [Related]
40. Discontinuation of nonsteroidal anti-inflammatory drug therapy and risk of acute myocardial infarction.
Fischer LM; Schlienger RG; Matter CM; Jick H; Meier CR
Arch Intern Med; 2004 Dec 13-27; 164(22):2472-6. PubMed ID: 15596638
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
